Pulmonary haptoglobin: A new marker for adenocarcinomas of the lung?

Pathology

Volumn 43, Issue 1, 2011, Pages 70-72

  Abdullah, M ^a   Marwitz, S ^a   Kahler D ^a   Schultz, H ^a   Kugler, C ^b   Zabel, P ^a   Vollmer, E ^a   Goldmann, T ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052203530     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e3283419f2a     Document Type: Letter

References (12)

1. World Health Organization (WHO). Cancer. Fact Sheet 297. Geneva: WHO, 2006.
2. Kaufmann O, Georgi T, Dietel M. Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. Hum Pathol 1997; 28: 1373-8. (Pubitemid 28013632)
3. Lee HY, Ahn MJ, Park YH, et al. Adenocarcinoma has an excellent outcome with pemetrexed treatment in Korean patients: a prospective, multicenter trial. Lung Cancer 2009; 66: 338-43.
4. Smit EF, Burgers SA, Biesma B, et al. Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer. J Clin Oncol 2009; 27: 2038-45.
5. Bharti A, Ma PC, Maulik G, et al. Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Anticancer Res 2004; 24: 1031-8. (Pubitemid 38624933)
6. Abdullah M, Schultz H, Kähler D, et al. Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues. Pathol Res Pract 2009; 205: 639-47.
7. Samak R, Edelstein R, Israel L. Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer. Cancer Immunol Immunother 1982; 13: 38-43. (Pubitemid 12081460)
8. Apffel CA, Peters JH. Tumors and serum glycoproteins. The 'symbodies'. Prog Exp Tumor Res 1969; 12: 1-54.
9. Heo SH, Lee SJ, Ryoo HM, et al. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 2007; 7: 4292-302.
10. Kossowska B, Ferens-Sieczkowska M, Gancarz R, et al. Fucosylation of serum glycoproteins in lung cancer patients. Clin Chem Lab Med 2005; 43: 361-9. (Pubitemid 41460640)
11. Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol 2010; 41: 20-5.
12. Travis WD. Pathology of lung cancer. Clin Chest Med 2002; 23: 65-81. (Pubitemid 34207764)